JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

Progyny

Progyny

PGNY

0.00

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ: PGNY) with a Neutral and raises the price target from $27 to $30.